Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Ranbaxy Laboratories
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
===Formation=== Ranbaxy was started by Ranbir Singh and Gurbax Singh in 1937 as a distributor for Japanese company [[Shionogi]]. The name Ranbaxy blends the names of its founders: '''Ran'''bir and Gur'''bax'''. Bhai Mohan Singh bought the company in 1952 from his cousins Ranbir and Gurbax. After Bhai Mohan Singh's son Parvinder Singh joined the company in 1967, the company saw an increase in scale. In the late 1990s, Ranbaxy formed a US company, Ranbaxy Pharmaceuticals Inc., in order to support its entry into the pharmaceutical market in United States.<ref>{{cite journal | url = https://www.pharmacytimes.com/publications/supplement/2013/generic-supplement-2013/ranbaxy-ranbaxy-continues-to-add-value-and-utility-to-us-product-portfolio | publisher = Pharmacy Times | website = pharmacytimes.com | title = Ranbaxy: Ranbaxy Continues to Add Value and Utility to US Product Portfolio | series = Generic Supplement 2013 | date = 23 July 2013 | quote = ''Ranbaxy [..] entered the U.S. generic pharmaceutical market in 1995 introducing its first product under the Ranbaxy Pharmaceuticals Inc. label in January 1998'' | access-date = 11 August 2018 | archive-date = 6 August 2020 | archive-url = https://web.archive.org/web/20200806135011/https://www.pharmacytimes.com/publications/supplement/2013/generic-supplement-2013/ranbaxy-ranbaxy-continues-to-add-value-and-utility-to-us-product-portfolio | url-status = dead }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)